Sean P. Collins MD, PhD, presented “Radiation Therapy Planning Using Advanced Imaging – Pearls and Pitfalls” during the 7th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2023.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Collins, Sean P. “Radiation Therapy Planning Using Advanced Imaging – Pearls and Pitfalls.” September 22, 2023. Accessed Nov 2024. https://grandroundsinurology.com/radiation-therapy-planning-using-advanced-imaging-pearls-and-pitfalls/
Radiation Therapy Planning Using Advanced Imaging – Pearls and Pitfalls – Summary
Dr. Sean P. Collins discusses radiation therapy planning for prostate cancer, emphasizing the role of advanced imaging technologies. He underscores how these technologies enhance the precision of targeting cancerous tissues while minimizing radiation exposure to surrounding healthy tissues.
Dr. Collins elaborates on various advanced imaging modalities, including multiparametric MRI and PET/CT scans. He believes that integrating these imaging techniques into the radiation therapy planning process can result in more precise dose distributions, leading to better tumor control and fewer adverse effects.
Despite the clear advantages, Dr. Collins also addresses the potential pitfalls associated with advanced imaging in radiation therapy planning. Variability in image quality, the potential for imaging artifacts, and the necessity for specialized expertise in interpreting complex imaging data are addressed, as well as ways to mitigate these challenges.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
ABOUT THE AUTHOR
Sean P. Collins, MD, PhD, is a clinical associate professor at Georgetown University Hospital in Washington, DC. He joined his twin brother Brian on the faculty of the cancer center in July of 2006 as an attending physician in radiation oncology. Dr. Collins graduated from the Medical Scientist Training Program (MSTP) at the University of Michigan in 2001. Professor Collins completed both an internship in surgery and a residency in radiation oncology at Georgetown University Hospital. His area of expertise is prostate cancer, for which he treats patients using the CyberKnife®, a technology that allows for more accurate targeting of radiation therapy. Dr. Collins is a physician-scientist, and his work focuses on developing prostate cancer treatment protocols using stereotactic body radiation therapy (SBRT) to minimize the toxicity of radiation dose escalation. To date, he has treated over 2000 prostate cancer patients with SBRT and has presented his work at major meetings and published multiple papers on his experience in peer reviewed journals.
